 |
|
|
| |
Impact of universal access to direct-acting antivirals in the profile of the Hepatitis C treated patient
|
| |
| |
EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
Jordi Llaneras1, Mar Riveiro Barciela1,2, Eulalia Pericas3, Nuria Boixareu1, Jordi Navarro4, Juan Ignacio Esteban1, Lluis Castells1, Cristina Marcos1, Maria Buti1,2, Rafael Esteban2,5. 1Vall Hebron
Hospital, Internal Medicine, Barcelona, Spain; 2CIBERehd; 3Vall Hebron Hospital, Information Management and Innovation, Barcelona, Spain; 4Vall Hebron Hospital, Infectious Diseases, Barcelona, Spain; 5Vall Hebron Hospital, Internal Medicine, Barcelona
|
| |
|
|
|
|
|
